Novartis AG at JPMorgan Healthcare Conference (Virtual) Transcript
Good afternoon. Welcome to the 39th JPMorgan Healthcare Conference. I'm Richard Vosser, European pharma analyst at JPMorgan. It gives me great pleasure to introduce Vas Narasimhan, CEO of Novartis, for this presentation.
Before I hand over to Vas, I'd remind you that if you would like to ask a question during the Q&A portion, and you can use the Q&A function at any time on the associated section of the website, and I'll read your question out at the appropriate time.
With that, I'd like to welcome Vas to the conference. Vas, over to you.
Thank you, Richard, and thanks, everyone, for joining today. I'd like to give you an update on our progress on our strategy for Novartis and give you some of the insights on how we progress over the recent years on delivering both on our operational performance but, more importantly, on our longer-term strategy to deliver consistent growth, consistent innovation and be a leading medicines
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
